| Gene symbol | TNFRSF8 | Synonyms | CD30, D1S166E, Ki-1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.22 | dbXrefs | |
| Description | TNF receptor superfamily member 8 | ||||
| GTO ID | GTC3939 |
| Trial ID | NCT06494371 |
| Disease | Hodgkin's Lymphoma | Anaplastic Large Cell Lymphoma |
| Altered gene | CD30 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LCAR-HL30 cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | An Open-label Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of CD30-Targeted LCAR-HL30 Cells in Patients With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma |
| Year | 2024 |
| Country | China |
| Company sponsor | Ruijin Hospital |
| Other ID(s) | LB2203-0001 |
| Cohort 1 | |||||||||
|
|||||||||